Taipei Municipal Wanfang Hospital

Medicine & Life Sciences

1. Taiwan 100%
2. Meta-Analysis 38%
3. Neoplasms 32%
4. Therapeutics 25%
5. Cohort Studies 25%
6. Population 24%
7. Systematic Reviews 23%
8. Pulmonary Veins 22%
9. Confidence Intervals 22%
10. Atrial Fibrillation 21%
11. Apoptosis 21%
12. Randomized Controlled Trials 18%
13. Stroke 16%
14. Mortality 16%
15. Neoplasm Metastasis 16%
16. Hepatocellular Carcinoma 15%
17. Odds Ratio 15%
18. Pharmaceutical Preparations 14%
19. Tuberculosis 14%
20. Colorectal Neoplasms 14%
21. Cardiac Myocytes 14%
22. Wounds and Injuries 14%
23. Proteins 13%
24. Databases 13%
25. Genes 13%
26. Calcium 13%
27. Reactive Oxygen Species 12%
28. Breast Neoplasms 12%
29. Survival 11%
30. ErbB Receptors 11%
31. Endothelial Cells 11%
32. Down-Regulation 11%
33. Lipopolysaccharides 10%
34. Lung 10%
35. National Health Programs 10%
36. Gene Expression 10%
37. Kidney 10%
38. Renal Dialysis 10%
39. Recurrence 10%
40. Prostatic Neoplasms 9%
41. Serum 9%
42. Elderly 9%
43. Incidence 9%
44. Mesenchymal Stem Cells 9%
45. Biomarkers 9%
46. Fibroblasts 9%
47. Inflammation 9%
48. Growth 9%
49. In Vitro Techniques 9%
50. Schizophrenia 9%
51. Autophagy 8%
52. Oxidative Stress 8%
53. Chronic Renal Insufficiency 8%
54. Skin 8%
55. Nitric Oxide 8%
56. Bone and Bones 8%
57. Adenocarcinoma of Lung 8%
58. Glioblastoma 8%
59. MicroRNAs 8%
60. Mouth Neoplasms 8%
61. Drug Therapy 8%
62. Non-Small Cell Lung Carcinoma 8%
63. Carcinoma 8%
64. Propensity Score 8%
65. Traumatic Brain Injury 8%
66. Liver 8%
67. Depression 8%
68. Lung Neoplasms 7%
69. Osteoporosis 7%
70. Cell Proliferation 7%
71. Phosphorylation 7%
72. Neoplastic Stem Cells 7%
73. Retrospective Studies 7%
74. Control Groups 7%
75. Radiotherapy 7%
76. Brain 7%
77. Safety 7%
78. Heart Atria 7%
79. Hip Fractures 7%
80. Type 2 Diabetes Mellitus 7%
81. Stomach Neoplasms 7%
82. Glucose 7%
83. Coronavirus 7%
84. Multidrug-Resistant Tuberculosis 7%
85. Logistic Models 7%
86. Stem Cells 7%
87. Homeostasis 7%
88. Heme Oxygenase-1 7%
89. Exercise 7%
90. Heart Failure 7%
91. Tomography 7%
92. Squamous Cell Carcinoma 7%
93. Hydroxymethylglutaryl-CoA Reductase Inhibitors 7%
94. Pneumonia 7%
95. Antioxidants 7%
96. Endothelin-1 7%
97. Peroxisome Proliferator-Activated Receptors 6%
98. Pain 6%
99. Macrophages 6%
100. Health 6%